Workflow
济民医疗(603222) - 2015 Q3 - 季度财报
ChiminChimin(SH:603222)2015-10-27 16:00

Financial Performance - Operating income decreased by 7.14% to CNY 345,398,472.36 for the year-to-date period compared to the same period last year[6] - Net profit attributable to shareholders decreased by 10.50% to CNY 39,090,683.28 for the year-to-date period compared to the same period last year[6] - Basic and diluted earnings per share decreased by 27.78% to CNY 0.26[7] - Total operating revenue for Q3 2015 was CNY 121,611,189.96, a decrease of 4.3% compared to CNY 127,096,479.30 in Q3 2014[42] - The net profit for Q3 2015 was CNY 5,562,574.07, down from CNY 7,816,613.71 in Q3 2014, indicating a decrease of about 29.0%[47] - The total profit for the first nine months of 2015 was CNY 27,234,130.18, down from CNY 37,073,317.61 in the same period of 2014, a decrease of about 26.4%[47] Asset and Equity Growth - Total assets increased by 25.81% to CNY 792,666,594.46 compared to the end of the previous year[6] - Net assets attributable to shareholders increased by 60.43% to CNY 708,371,024.30 compared to the end of the previous year[6] - The company's total assets as of September 30, 2015, amounted to CNY 792,666,594.46, an increase from CNY 630,039,997.04 at the beginning of the year, reflecting a growth of approximately 25.7%[34] - Shareholders' equity increased to CNY 626,021,569.04 from CNY 374,814,850.53, reflecting a growth of 67%[40] Cash Flow Analysis - Net cash flow from operating activities decreased by 9.58% to CNY 49,241,969.28 for the year-to-date period compared to the same period last year[6] - Total cash inflow from operating activities is CNY 387,608,252.43, down from CNY 426,162,908.97, reflecting a decline of approximately 9.0%[51] - The net cash flow from investment activities is -CNY 89,117,755.10, worsening from -CNY 35,358,764.69 year-over-year[51] - The net cash flow from financing activities is CNY 106,153,791.17, a turnaround from -CNY 75,314,957.96 in the same period last year[51] Shareholder Information - The total number of shareholders reached 16,741 at the end of the reporting period[10] - The largest shareholder, Shuangge Group Co., Ltd., holds 36.20% of the shares[10] Related Party Transactions and Commitments - The company has implemented measures to reduce related party transactions since 2014, with ongoing compliance confirmed[16] - The company reported a commitment to fulfill public commitments and constraints on related party transactions[16] - The company has pledged to reduce related party transactions and maintain independence in assets, personnel, finance, and operations[22] - The company will not engage in any new procurement transactions with Xiliyou and will eliminate any other related party transactions with them[23] Investment and Financial Management - The company reported a significant increase in investment income, amounting to ¥2,671,907.54, attributed to higher wealth management returns[13] - The company's financial expenses decreased by 148.88% to -¥1,383,812.42, mainly due to reduced average loans and increased deposits[12] - The company has pledged to maintain independence from its controlling shareholders in terms of financial and operational decisions[29] Government Subsidies and Other Income - The company received government subsidies amounting to CNY 1,146,773.80 for the year-to-date period[8] - The cash received from investment activities increased by 82,943.54% to ¥265,570,000.00, primarily due to an increase in wealth management products[13]